5F-ADB: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{Short description|Synthetic cannabinoid}}
{{DISPLAYTITLE:5F-ADB}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477318752
| IUPAC_name = Methyl (2S)-2-{{(1-(5-fluoropentyl)-1H-indazole-3-carbonyl)}}amino-3,3-dimethylbutanoate
| image = 5F-ADB_structure.png
| image_size = 200px
}}


'''5F-ADB''' is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the [[cannabinoid receptor]]s and has been associated with numerous adverse health effects.
== Overview ==
[[File:5F-ADB_structure.png|thumb|right|Chemical structure of 5F-ADB]]
'''5F-ADB''' (also known as 5F-MDMB-PINACA) is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the [[cannabinoid receptor]]s and has been associated with numerous adverse health effects.


==Chemical structure and properties==
== Chemical Properties ==
5F-ADB is chemically classified as an indazole-based synthetic cannabinoid. Its structure includes a 5-fluoropentyl chain, which is a common feature in many synthetic cannabinoids. The compound is a derivative of [[ADB-PINACA]], with the addition of a fluorine atom on the pentyl chain.
5F-ADB is classified as an indazole-based synthetic cannabinoid. Its chemical structure includes a fluoropentyl chain, which is a common feature in many synthetic cannabinoids. The presence of the fluorine atom is believed to enhance its potency and metabolic stability.


==Pharmacology==
== Pharmacology ==
5F-ADB acts as a potent agonist at the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] cannabinoid receptors. These receptors are part of the [[endocannabinoid system]], which plays a role in regulating various physiological processes including mood, memory, and pain sensation.
5F-ADB acts as a full agonist at the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] cannabinoid receptors. These receptors are part of the [[endocannabinoid system]], which plays a role in regulating various physiological processes such as mood, appetite, and pain sensation.


===Effects===
== Effects and Toxicity ==
The effects of 5F-ADB are similar to those of other synthetic cannabinoids and can include euphoria, relaxation, altered perception, and increased appetite. However, it can also cause severe adverse effects such as anxiety, paranoia, tachycardia, and in some cases, [[seizure]]s or [[psychosis]].
The effects of 5F-ADB are similar to those of other synthetic cannabinoids, including euphoria, relaxation, and altered perception. However, it can also cause severe adverse effects such as [[tachycardia]], [[hypertension]], [[nausea]], [[vomiting]], [[anxiety]], and [[hallucinations]]. In some cases, it has been linked to [[acute kidney injury]] and [[death]].


==Legal status==
== Legal Status ==
Due to its potential for abuse and lack of medical use, 5F-ADB has been classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "[[new psychoactive substances]]".
Due to its potential for abuse and harmful effects, 5F-ADB has been classified as a controlled substance in many countries. It is often included in the list of substances banned under [[analogue drug laws]].


==Health risks==
== Synthesis and Detection ==
The use of 5F-ADB has been associated with numerous health risks. Acute intoxication can lead to severe cardiovascular and neurological effects. Chronic use may result in dependence and withdrawal symptoms. There have been reports of fatalities linked to the use of 5F-ADB, often in combination with other substances.
The synthesis of 5F-ADB involves the reaction of an indazole core with a fluoropentyl chain and a carboxamide group. Detection of 5F-ADB in biological samples can be challenging due to its rapid metabolism, but advanced techniques such as [[mass spectrometry]] and [[gas chromatography]] are used for its identification.


==Synthesis==
== Related Compounds ==
The synthesis of 5F-ADB involves the reaction of indazole with a fluoropentyl halide, followed by the addition of a carboxamide group. The process requires careful control of reaction conditions to ensure the correct isomer is produced.
5F-ADB is structurally related to other synthetic cannabinoids such as [[AB-FUBINACA]], [[ADB-FUBINACA]], and [[5F-AMB]]. These compounds share similar pharmacological profiles and are often found in synthetic cannabis products.


==Related pages==
== Related Pages ==
* [[Synthetic cannabinoid]]
* [[Synthetic cannabinoids]]
* [[Cannabinoid receptor]]
* [[Cannabinoid receptor]]
* [[Endocannabinoid system]]
* [[Endocannabinoid system]]
* [[Designer drug]]
* [[Drug metabolism]]


[[Category:Synthetic cannabinoids]]
[[Category:Synthetic cannabinoids]]
[[Category:Designer drugs]]
[[Category:Designer drugs]]
[[Category:Indazolecarboxamides]]

Latest revision as of 03:56, 13 February 2025


Overview[edit]

Chemical structure of 5F-ADB

5F-ADB (also known as 5F-MDMB-PINACA) is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the cannabinoid receptors and has been associated with numerous adverse health effects.

Chemical Properties[edit]

5F-ADB is classified as an indazole-based synthetic cannabinoid. Its chemical structure includes a fluoropentyl chain, which is a common feature in many synthetic cannabinoids. The presence of the fluorine atom is believed to enhance its potency and metabolic stability.

Pharmacology[edit]

5F-ADB acts as a full agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as mood, appetite, and pain sensation.

Effects and Toxicity[edit]

The effects of 5F-ADB are similar to those of other synthetic cannabinoids, including euphoria, relaxation, and altered perception. However, it can also cause severe adverse effects such as tachycardia, hypertension, nausea, vomiting, anxiety, and hallucinations. In some cases, it has been linked to acute kidney injury and death.

Legal Status[edit]

Due to its potential for abuse and harmful effects, 5F-ADB has been classified as a controlled substance in many countries. It is often included in the list of substances banned under analogue drug laws.

Synthesis and Detection[edit]

The synthesis of 5F-ADB involves the reaction of an indazole core with a fluoropentyl chain and a carboxamide group. Detection of 5F-ADB in biological samples can be challenging due to its rapid metabolism, but advanced techniques such as mass spectrometry and gas chromatography are used for its identification.

Related Compounds[edit]

5F-ADB is structurally related to other synthetic cannabinoids such as AB-FUBINACA, ADB-FUBINACA, and 5F-AMB. These compounds share similar pharmacological profiles and are often found in synthetic cannabis products.

Related Pages[edit]